- The discussion orbited encompassing the state of the indigenous vaccine, Covaxin, and the strategies to make it ready in India and the rest of the world.
THD NEWSDESK, NEW DELHI: Dr. Krishna Ella, Bharat Biotech’s Chairman, and MD and Suchitra Ella, Joint MD called on the Vice President of India, M Venkaiah Naidu in Hyderabad
The discussion orbited encompassing the state of the indigenous vaccine, Covaxin, and the strategies to make it ready in India and the rest of the world. It is developed by Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR) – National Institute of Virology (NIV). This indigenous, inactivated vaccine is developed and produced in Bharat Biotech’s BSL-3 (Bio-Safety Level 3) bio-containment facility.
Lately, the Prime Minister, Narendra Modi visited Bharat Biotech and analyzed the situation of COVAXIN. It was followed by a visit of 70 Ambassadors and High Commissioners from several nations to the Bharat Biotech facility at Genome Valley, Hyderabad.
During the intercommunication, the Vice President stressed the importance of public-private partnerships in coming out with indigenous world-class products and lauded the collaboration between the ICMR and Bharat Biotech.
Source: Express Pharma